Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Ptc Therapeutics
(NQ:
PTCT
)
34.15
+0.72 (+2.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ptc Therapeutics
< Previous
1
2
3
4
5
6
Next >
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
August 19, 2024
The Relative Strength (RS) Rating for PTC Therapeutics stock climbed into a new percentile Monday, with a rise from 80 to 83.
Via
Investor's Business Daily
PTCT Stock Earnings: PTC Therapeutics Misses EPS, Beats Revenue for Q2 2024
August 08, 2024
PTCT stock results show that PTC Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 10, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 03, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Recap: PTC Therapeutics Q4 Earnings
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Earnings Preview: PTC Therapeutics
February 28, 2024
Via
Benzinga
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
June 28, 2024
Via
Benzinga
PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again
June 28, 2024
The company plans to ask for another re-examination for its drug in Europe.
Via
Investor's Business Daily
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
June 21, 2024
Via
Benzinga
PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder
June 20, 2024
PTC Therapeutics released interim results from its Phase 2 PIVOT-HD study on PTC518 for Huntington's disease. The FDA has lifted the partial clinical hold on the program.
Via
Benzinga
Exposures
Product Safety
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
June 04, 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate
Via
InvestorPlace
Analyst Expectations for PTC Therapeutics's Future
November 20, 2023
Via
Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 20, 2024
Via
Benzinga
European Commission Requests Reevaluation Of Opinion On PTC Therapeutics' Duchenne Dystrophy Drug; Pauses Annual Guidance
May 20, 2024
PTC Therapeutics announced that the European Commission has asked the CHMP to re-evaluate its negative opinion on the renewal of Translarna's conditional marketing authorization, keeping it available...
Via
Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
Via
Benzinga
PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
May 20, 2024
The EC is asking its committee to reexamine its decision on Translarna.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 20, 2024
Via
Benzinga
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
May 01, 2024
PTC Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 61 to 72.
Via
Investor's Business Daily
PTCT Stock Earnings: PTC Therapeutics Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
PTCT stock results show that PTC Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
February 11, 2024
Bad news for one player does not always equal good news for another.
Via
The Motley Fool
PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug
January 26, 2024
European regulators will likely force PTC Therapeutics to pull its drug, Translarna, from the market.
Via
Investor's Business Daily
PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe
January 26, 2024
CHMP issues negative opinion on PTC Therapeutics' Translarna for Duchenne Muscular Dystrophy. CEO expresses disappointment.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 27, 2023
Via
Benzinga
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
October 27, 2023
In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a
Via
Benzinga
ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program
October 27, 2023
Align Technology stock is rising on Friday after the company announced plans to repurchase $250 million worth of ALGN shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 27, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.